• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种对 2022 年 B.1.1.529(奥密克戎)BA.2 引起的疫情期间日本学校环境中 COVID-19 聚集性感染的降低作用

Vaccine-induced reduction of COVID-19 clusters in school settings in Japan during the epidemic wave caused by B.1.1.529 (Omicron) BA.2, 2022.

机构信息

Kyoto University School of Public Health, Yoshida-Konoe, Sakyo-ku, Kyoto 606-8601, Japan.

出版信息

Math Biosci Eng. 2024 Sep 12;21(9):7087-7101. doi: 10.3934/mbe.2024312.

DOI:10.3934/mbe.2024312
PMID:39483074
Abstract

Clusters of COVID-19 in high-risk settings, such as schools, have been deemed a critical driving force of the major epidemic waves at the societal level. In Japan, the vaccination coverage among students remained low up to early 2022, especially for 5-11-year-olds. The vaccination of the student population only started in February 2022. Given this background and considering that vaccine effectiveness against school transmission has not been intensively studied, this paper proposes a mathematical model that links the occurrence of clustering to the case count among populations aged 0-19, 20-59, and 60+ years of age. We first estimated the protected (immune) fraction of each age group either by infection or vaccination and then linked the case count in each age group to the number of clusters via a time series regression model that accounts for the time-varying hazard of clustering per infector. From January 3 to May 30, 2022, there were 4,722 reported clusters in school settings. Our model suggests that the immunity offered by vaccination averted 226 (95% credible interval: 219-232) school clusters. Counterfactual scenarios assuming elevated vaccination coverage with faster roll-out reveal that additional school clusters could have been averted. Our study indicates that even relatively low vaccination coverage among students could substantially lower the risk of clustering through vaccine-induced immunity. Our results also suggest that antigenically updated vaccines that are more effective against the variant responsible for the ongoing epidemic may greatly help decrease not only the incidence but also the unnecessary loss of learning opportunities among school-age students.

摘要

在高风险环境(如学校)中出现的 COVID-19 集群被认为是社会层面重大疫情浪潮的关键驱动因素。在日本,直到 2022 年初,学生的疫苗接种率仍然很低,尤其是 5-11 岁的儿童。学生群体的疫苗接种仅在 2022 年 2 月开始。鉴于这种背景,并且考虑到针对学校传播的疫苗有效性尚未得到深入研究,本文提出了一个数学模型,将集群的发生与 0-19 岁、20-59 岁和 60 岁以上人群的病例数联系起来。我们首先通过感染或接种来估计每个年龄组的保护(免疫)比例,然后通过时间序列回归模型将每个年龄组的病例数与集群数量联系起来,该模型考虑了每个感染者的集群时间变化风险。从 2022 年 1 月 3 日至 5 月 30 日,学校环境中报告了 4722 个集群。我们的模型表明,疫苗提供的免疫力避免了 226 个(95%可信区间:219-232)学校集群。假设疫苗接种覆盖率提高且推出速度加快的反事实情景表明,可能会避免更多的学校集群。我们的研究表明,即使学生的疫苗接种率相对较低,通过疫苗诱导的免疫力也可以大大降低集群的风险。我们的研究结果还表明,针对导致当前疫情的变异体更有效的抗原更新疫苗可能会极大地帮助减少不仅是发病率,还有学龄学生不必要的学习机会损失。

相似文献

1
Vaccine-induced reduction of COVID-19 clusters in school settings in Japan during the epidemic wave caused by B.1.1.529 (Omicron) BA.2, 2022.疫苗接种对 2022 年 B.1.1.529(奥密克戎)BA.2 引起的疫情期间日本学校环境中 COVID-19 聚集性感染的降低作用
Math Biosci Eng. 2024 Sep 12;21(9):7087-7101. doi: 10.3934/mbe.2024312.
2
Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.模型估计的美国小学相关 SARS-CoV-2 传播、缓解干预措施与疫苗接种率之间的关联,按当地发病水平分类。
JAMA Netw Open. 2022 Feb 1;5(2):e2147827. doi: 10.1001/jamanetworkopen.2021.47827.
3
Indirect effectiveness of COVID-19 vaccines in the pre-omicron and omicron periods: A nation-wide test-negative case-control study in Brazil.COVID-19 疫苗在奥密克戎前和奥密克戎时期的间接效果:巴西全国性的病例对照研究。
Int J Infect Dis. 2024 Nov;148:107241. doi: 10.1016/j.ijid.2024.107241. Epub 2024 Sep 18.
4
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
5
How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.辉瑞-BioNTech 信使核糖核酸疫苗(BNT162b2)对 SARS-CoV-2 传播和感染的有效性如何?2021 年 7 月至 2022 年 9 月在摩纳哥开展的一项全国性方案分析。
BMC Med. 2024 Jun 5;22(1):227. doi: 10.1186/s12916-024-03444-6.
6
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
7
Impact of the emergence of severe acute respiratory syndrome coronavirus 2 omicron variants on routine childhood immunization in Japan.奥密克戎变异株的出现对日本常规儿童免疫接种的影响。
Vaccine. 2024 Aug 30;42(21):126137. doi: 10.1016/j.vaccine.2024.07.038. Epub 2024 Jul 23.
8
BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.新加坡儿童和青少年中 BNT162b2 疫苗对奥密克戎的保护作用以及既往感染变异株和接种顺序的影响:一项基于人群的队列研究。
Lancet Child Adolesc Health. 2023 Jul;7(7):463-470. doi: 10.1016/S2352-4642(23)00101-3. Epub 2023 May 15.
9
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.新冠病毒疫苗接种与儿童感染新冠病毒及住院的发生率
JAMA Netw Open. 2024 Apr 1;7(4):e247822. doi: 10.1001/jamanetworkopen.2024.7822.
10
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo.评估 2022 年初奥密克戎变异株(B.1.1.529)流行期间的 COVID-19 疫苗接种计划,东京。
BMC Infect Dis. 2023 Oct 31;23(1):748. doi: 10.1186/s12879-023-08748-1.

引用本文的文献

1
Impact of Vaccination and Prior Infection on SARS-CoV-2 Viral Load in Preschool Children During the Omicron Pandemic.在奥密克戎大流行期间,疫苗接种和既往感染对学龄前儿童新冠病毒载量的影响
Vaccines (Basel). 2025 Aug 11;13(8):850. doi: 10.3390/vaccines13080850.